Raquibul Hannan, M.D., Ph.D.
Affiliations: | University of Texas Southwestern Medical Center, Dallas, TX, United States |
Area:
radiation oncologyWebsite:
http://profiles.utsouthwestern.edu/profile/125338/raquibul-hannan.htmlGoogle:
"Raquibul Hannan"Bio:
B.S. NYU; undergrad research at Cooper Union. For subsequent details see http://profiles.utsouthwestern.edu/profile/125338/raquibul-hannan-biography.html
Mean distance: 39813 | S | N | B | C | P |
Parents
Sign in to add mentor| Robert Q. Topper | research assistant | The Cooper Union | ||
| (publication; worked with RQT while an undergraduate at NYU) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Anderson AC, Ho J, Hall ET, et al. (2024) Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review. Future Oncology (London, England). 1-16 |
| Sartor O, Karrison TG, Sandler HM, et al. (2024) Corrigendum to "Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial" [Eur. Eurol. 84(2) (2023) 156-163]. European Urology |
| Sartor O, Karrison TG, Sandler HM, et al. (2023) Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial. European Urology |
| Huynh MA, Tang C, Siva S, et al. (2022) Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers. European Urology Oncology |
| Christensen M, Hannan R. (2022) The Emerging Role of Radiation Therapy in Renal Cell Carcinoma. Cancers. 14 |
| Montalvo SK, Meng B, Lin MH, et al. (2022) Case Report: Adaptive radiotherapy in the radiation salvage of prostate cancer. Frontiers in Oncology. 12: 898822 |
| Chen L, Gannavarapu BS, Desai NB, et al. (2022) Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer. Frontiers in Oncology. 12: 779182 |
| Hannan R, Christensen M, Hammers H, et al. (2021) Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer. European Urology Oncology |
| Hannan R, Salamekh S, Desai NB, et al. (2021) Stereotactic Ablative Radiotherapy for High-Risk Prostate Cancer-a Prospective Multi-level MRI-based Dose Escalation Trial. International Journal of Radiation Oncology, Biology, Physics |
| Schoenhals JE, Mohamad O, Christie A, et al. (2021) Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma. Advances in Radiation Oncology. 6: 100692 |